Spatial Genomics

Pasadena, United States

Spatial Genomics is a developer of sequential fluorescence in situ hybridization (seqFISH) technology.

$56.0M raised

Feb 2022

Series A

Biotechnology Health Care Medical

Top Investors

Fulgent Therapeutics 12 West Capital

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Spatial Genomics

How much funding has Spatial Genomics raised?

Spatial Genomics has raised $56.0M in total funding. The most recent round was Series A. The last funding was announced in February 2022.

Who are Spatial Genomics's investors?

Spatial Genomics's investors include Fulgent Therapeutics, 12 West Capital.

Where is Spatial Genomics headquartered?

Spatial Genomics is headquartered in Pasadena, United States.

What does Spatial Genomics do?

Spatial Genomics is a developer of sequential fluorescence in situ hybridization (seqFISH) technology.

What stage is Spatial Genomics at?

Spatial Genomics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 23, 2022.

MLA

"Spatial Genomics — Funding & Investors." VCBacked, February 23, 2022, https://www.vcbacked.co/company/spatial-genomics. Accessed July 2, 2026.

APA

VCBacked. (2022). Spatial Genomics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/spatial-genomics

Wikipedia (cite web)

{{cite web |title=Spatial Genomics — Funding & Investors |url=https://www.vcbacked.co/company/spatial-genomics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 23, 2022.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K